209 related articles for article (PubMed ID: 23204807)
41. Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.
Kim KS; Lee WK
Jpn J Ophthalmol; 2011 Jul; 55(4):370-377. PubMed ID: 21647565
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal bevacizumab to treat choroidal neovascularization following photodynamic therapy in central serous choroidopathy.
Montero JA; Ruiz-Moreno JM; Fernandez-Muñoz M
Eur J Ophthalmol; 2011; 21(4):503-5. PubMed ID: 21279982
[TBL] [Abstract][Full Text] [Related]
43. OCT angiography in choroidal neovascularization secondary to choroidal osteoma.
Cennamo G; Romano MR; Iovino C; Velotti N; Breve MA; de Crecchio G; Cennamo G
Acta Ophthalmol; 2017 Mar; 95(2):e152-e154. PubMed ID: 27273327
[No Abstract] [Full Text] [Related]
44. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
[TBL] [Abstract][Full Text] [Related]
45. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
[TBL] [Abstract][Full Text] [Related]
46. Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration.
Bakri SJ; Couch SM; McCannel CA; Edwards AO
Retina; 2009 May; 29(5):573-8. PubMed ID: 19430278
[TBL] [Abstract][Full Text] [Related]
47. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
48. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
49. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
[TBL] [Abstract][Full Text] [Related]
50. Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration.
Datseris I; Kontadakis GA; Diamanti R; Datseris I; Pallikaris IG; Theodossiadis P; Tsilimbaris MK
Semin Ophthalmol; 2015 Mar; 30(2):112-7. PubMed ID: 24117412
[TBL] [Abstract][Full Text] [Related]
51. Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.
Chen E; Kaiser RS; Vander JF
Retina; 2007; 27(4):445-50. PubMed ID: 17420696
[TBL] [Abstract][Full Text] [Related]
52. Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane.
Shah N; Shah U
Indian J Ophthalmol; 2008; 56(2):163-4. PubMed ID: 18292635
[TBL] [Abstract][Full Text] [Related]
53. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Spandau UH; Jonas JB
Acta Ophthalmol Scand; 2007 May; 85(3):340-1. PubMed ID: 17488467
[No Abstract] [Full Text] [Related]
54. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
55. Choroidal Osteoma Accompanied by Proliferative Diabetic Retinopathy.
Choi HS; Kim YK; Park SP
Korean J Ophthalmol; 2018 Dec; 32(6):521-522. PubMed ID: 30549478
[No Abstract] [Full Text] [Related]
56. Treatment of choroidal neovascularization using intravitreal bevacizumab.
Pedersen R; Soliman W; Lund-Andersen H; Larsen M
Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
[TBL] [Abstract][Full Text] [Related]
57. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.
Kapoor KG; Bakri SJ
J Ocul Pharmacol Ther; 2013 May; 29(4):444-7. PubMed ID: 23581613
[TBL] [Abstract][Full Text] [Related]
58. Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.
Al-Gharbi N; Al Abdulsalam O; Al Habash A
Middle East Afr J Ophthalmol; 2015; 22(2):245-8. PubMed ID: 25949086
[TBL] [Abstract][Full Text] [Related]
59. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
Rush RB; Rush SW; Aragon AV; Ysasaga JE
Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
